X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (126) 126
life sciences & biomedicine (125) 125
p70s6k (111) 111
humans (79) 79
ribosomal protein s6 kinases, 70-kda - metabolism (65) 65
animals (63) 63
phosphorylation (56) 56
signal transduction (51) 51
cell biology (45) 45
biochemistry & molecular biology (43) 43
male (38) 38
mtor (38) 38
rats (31) 31
proteins (29) 29
phosphorylation - drug effects (26) 26
apoptosis (25) 25
proto-oncogene proteins c-akt - metabolism (25) 25
signal transduction - drug effects (25) 25
tor serine-threonine kinases - metabolism (25) 25
cell line, tumor (24) 24
female (24) 24
akt (23) 23
cells, cultured (23) 23
mice (23) 23
sirolimus - pharmacology (23) 23
kinases (22) 22
oncology (22) 22
tor serine-threonine kinases (20) 20
adult (19) 19
phosphatidylinositol 3-kinases - metabolism (19) 19
cancer (17) 17
protein-serine-threonine kinases - metabolism (16) 16
dose-response relationship, drug (15) 15
middle aged (15) 15
neurosciences (15) 15
phosphoproteins - metabolism (15) 15
protein kinases - metabolism (15) 15
rats, wistar (15) 15
aged (14) 14
apoptosis - drug effects (14) 14
biophysics (14) 14
protein kinases (14) 14
protein synthesis (14) 14
research (14) 14
4e-bp1 (13) 13
enzyme activation - drug effects (13) 13
neurosciences & neurology (13) 13
pharmacology & pharmacy (13) 13
protein biosynthesis (13) 13
rapamycin (13) 13
cell cycle (12) 12
enzyme inhibitors - pharmacology (12) 12
p70 (12) 12
ribosomal protein s6 kinases, 70-kda - antagonists & inhibitors (12) 12
ribosomal protein s6 kinases, 70-kda - genetics (12) 12
signal transduction - physiology (12) 12
physiological aspects (11) 11
rodents (11) 11
tor protein (11) 11
analysis (10) 10
cell line (10) 10
enzyme activation (10) 10
insulin (10) 10
muscle, skeletal - metabolism (10) 10
physiology (10) 10
pi3k (10) 10
time factors (10) 10
aged, 80 and over (9) 9
autophagy (9) 9
biomedicine (9) 9
blotting, western (9) 9
cell proliferation - drug effects (9) 9
health aspects (9) 9
life sciences (9) 9
proto-oncogene proteins c-akt (9) 9
ribosomal protein s6 kinases - metabolism (9) 9
signaling (9) 9
tumor cells, cultured (9) 9
amino acids (8) 8
gene expression (8) 8
insulin - pharmacology (8) 8
mtor, mammalian target of rapamycin (8) 8
mutation (8) 8
phosphatidylinositol 3-kinases - antagonists & inhibitors (8) 8
proliferation (8) 8
protein kinase inhibitors - pharmacology (8) 8
research article (8) 8
ampk (7) 7
care and treatment (7) 7
carrier proteins - metabolism (7) 7
cell growth (7) 7
cell proliferation (7) 7
flow cytometry (7) 7
immunohistochemistry (7) 7
mapk (7) 7
mapk, mitogen-activated protein kinase (7) 7
mice, nude (7) 7
phosphatidylinositol 3-kinases - genetics (7) 7
pkb, protein kinase b (7) 7
protein biosynthesis - drug effects (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FEBS letters, ISSN 0014-5793, 2006, Volume 580, Issue 1, pp. 107 - 114
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 5, pp. 867 - 875
Journal Article
Neoplasia, ISSN 1476-5586, 2014, Volume 16, Issue 10, pp. 845 - 860
Abstract Selumetinib (AZD6244, ARRY-142886) is a MEK1/2 inhibitor that has gained interest as an anti-tumour agent. We have determined the degree of... 
Oncology | RPS6, ribosomal protein S6 | p70S6K, p70 S6 kinase | CRC, colorectal cancer | RSK, p90 ribosomal S6 kinase | ERK, extracellular signal-regulated kinase | MEK, mitogen-activated protein kinase | Life Sciences & Biomedicine | Science & Technology | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Molecular Targeted Therapy | Quinolines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Colorectal Neoplasms - drug therapy | Phosphorylation - drug effects | Colorectal Neoplasms - metabolism | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Ribosomal Protein S6 Kinases, 70-kDa - genetics | Proto-Oncogene Proteins - genetics | Imidazoles - pharmacology | Enzyme Activation - drug effects | Piperazines - pharmacology | Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases | Mitogen-Activated Protein Kinase 3 - metabolism | Proto-Oncogene Proteins B-raf - genetics | Ribosomal Protein S6 - metabolism | Cell Line, Tumor | Benzimidazoles - pharmacology | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Mutation | Cell Cycle - drug effects | Colorectal Neoplasms - pathology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Index Medicus
Journal Article
Cellular signalling, ISSN 0898-6568, 09/2006, Volume 18, Issue 9, pp. 1351 - 1359
... extracellular regulated kinases (ERKs), p38 mitogen-activated protein kinases (MAPKs), and phosphatidylinositol-3 kinase (PI3K... 
Protein kinase A | Mitogen-activated protein kinase | Follicle-stimulating hormone | Female reproduction | Hypoxia-induced factor 1 | Histone H3 | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cyclic AMP-Dependent Protein Kinases - metabolism | Follicle Stimulating Hormone - metabolism | Tumor Suppressor Proteins - metabolism | Granulosa Cells - physiology | Gene Expression Regulation | Protein Tyrosine Phosphatases - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Animals | Forkhead Transcription Factors - metabolism | Cyclic AMP Response Element-Binding Protein - metabolism | Female | Signal Transduction - physiology | p38 Mitogen-Activated Protein Kinases - metabolism | Enzyme Activation | Histones - metabolism | Tyrosine | Chromatin | Phosphatases | Corticosteroids | Peptides | Tuberous sclerosis | Glycoproteins | DNA binding proteins | Hormones | Gene expression | Phosphatidylinositol | Luteinizing hormone | Mitogens | Vascular endothelial growth factor | Protein kinases | Growth factors | Protein binding | Index Medicus | GIOT-1, gonadotropin-inducible ovarian transcription factor-1 | p70S6K, p70 ribosomal S6 kinase | TGFβ, transforming growth factor β | EGF, epidermal growth factor | CREB, cAMP response element binding protein | PDE, phosphodiesterase | R, PKA regulatory subunits | GPCR, G-protein-coupled receptor | MAP2D, microtubule-associated protein 2D | Sp1 | Epac, exchange proteins activated by cAMP | PI3K, phosphatidylinositol 3-kinase | IGF, insulin-like growth factor | mTOR, mammalian target of rapamycin | AKAP, A kinase anchoring protein | Sp3, specific protein 1 | PKI, PKA inhibitor peptide | PKC, protein kinase C | SCC, P450 cholesterol side chain cleavage | VEGF, vascular endothelial growth factor | CBP, CREB binding protein | ERK, extracellular regulated kinase | MNK, MAPK-interacting kinase | Aromatase, P450 aromatase | ChIP, chromatin immunoprecipitation assay | HIF-1, hypoxia-induced factor-1 | Egr-1, early growth response protein-1 | LH, luteinizing hormone | MEK, mitogen- and extracellular-regulated kinase kinase | TSC, tuberous sclerosis complex tumor suppressor gene | SF-1, steroidogenic factor-1 | SGK, serum glucocorticoid kinase | RSK, p90 ribosomal S6 protein kinase | LRH-1, liver receptor homolog-1 | MAPK, mitogen-activated protein kinase | PKA, protein kinase A | PTP, protein tyrosine phosphatase | FSH, follicle-stimulating hormone | MK, MAPK-activated protein kinases
Journal Article
Biochemical journal, ISSN 1470-8728, 09/2007, Volume 407, Issue 2, pp. 231 - 241
...) were differentially phosphorylated in response to IGF-1, EGF, PMA and AICAR. The binding of 14-3-3 proteins to HA–AS160... 
14-3-3 | Akt/protein kinase B (PKB) | GTPase-activating protein (GAP) | p90 ribosomal S6 kinase (RSK) | Akt substrate of 160 kDa (AS160) | Serum- and glucocorticoid-induced protein kinase (SGK) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Line | Insulin-Like Growth Factor I - pharmacology | Phosphorylation | Humans | GTPase-Activating Proteins - metabolism | Insulin | Amino Acids | Aminoimidazole Carboxamide - pharmacology | Hypoglycemic Agents - pharmacology | 14-3-3 Proteins - metabolism | Ribonucleotides - pharmacology | Aminoimidazole Carboxamide - analogs & derivatives | Protein Binding | Epidermal Growth Factor - pharmacology | Binding Sites | Index Medicus | ACC, acetyl-CoA carboxylase | AGC kinase, protein kinase A | AICAR, 5-amino-4-imidazolecarboxamide1-β-D-ribofuranoside | PI3K, phosphoinositide 3-kinase | EGF, epidermal growth factor | TOS motif, mTOR signalling motif | PAS, phospho-Akt substrate | pSer, phosphorylated serine | TSC, tuberous sclerosis complex | AS160, Akt substrate of 160 kDa | PKB, protein kinase B (also known as Akt) | AMPK, AMP-activated protein kinase | RSK, p90 ribosomal S6 kinase | DSP, dithiobis(succinimidyl propionate) | protein kinase C-family | ERK, extracellular-signal-regulated kinase | PDK1, phosphoinositide-dependent kinase 1 | protein kinase B (PKB) | IGF-1, insulin-like growth factor-1 | Akt substrate of 160 kDa (AS160) | GLUT4, glucose transporter 4 | protein kinase G | mTOR, mammalian target of rapamycin | TORC1, mTOR–raptor (regulatory associated protien of mTOR) complex | 4E-BP1, eukaryotic initiation factor 4E-binding protein 1 | GST, glutathione S-transferase | PKC, protein kinase C | PP2A, protein phosphatase 2A | Akt | SGK, serum- and glucocorticoid-induced protein kinase | HA, haemagglutinin | GSV, GLUT4 storage vesicle | p70S6K, p70 S6 kinase | PTB, phosphotyrosine binding domain | pThr, phosphorylated threonine | GAP, GTPase-activating protein | HEK-293, human embryonic kidney-293 | IRAP, insulin-responsive aminopeptidase | Rheb, Ras enriched in brain | serum- and glucocorticoid-induced protein kinase (SGK) | MAPK, mitogen-activated protein kinase
Journal Article
FEBS letters, ISSN 0014-5793, 2001, Volume 496, Issue 1, pp. 44 - 48
The specificity of 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB), an ATP/GTP competitive inhibitor of protein kinase casein kinase-2 (CK2... 
Casein kinase | Inhibitor | Casein kinase-2 | Protein phosphorylation | Protein kinase | nCK, native casein kinase | OA, okadaic acid | PRAK, p38-regulated/activated kinase | CSK, C-terminal Src kinase | AMPK, AMP-activated protein kinase | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | MAPKAP, MAPK-activated protein kinase | p70S6K, p70 ribosomal protein S6 kinase | CK, casein kinase | SAPK, stress-activated protein kinase | PDK, 3-phosphoinositide-dependent kinase | ROCK, Rho-dependent protein kinase | CDK, cyclin-dependent kinase | G-CK, Golgi casein kinase | PKC, protein kinase C | MKK, MAPK kinase (also called MEK) | PKA, cAMP-dependent protein kinase | DRB, 1-(β-D-ribofuranosyl)-5,6-dichlorobenzimidazole | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | rCK, recombinant casein kinase | ERK, extracellular signal-regulated kinase | HS1, hematopoietic lineage cell-specific protein 1 | MSK, mitogen- and stress-activated protein kinase | TBB, 4,5,6,7-tetrabromo-2-azabenzimidazole or 4,5,6,7-tetrabromobenzotriazole | MAPK, mitogen-activated protein kinase | SGK, serum- and glucocorticoid-induced kinase | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Protein Kinases - metabolism | Jurkat Cells - cytology | Protein Kinases - drug effects | Casein Kinase II | Emodin - pharmacology | Jurkat Cells - metabolism | Humans | Enzyme Inhibitors - pharmacology | Protein-Serine-Threonine Kinases - genetics | Substrate Specificity | Adenosine Triphosphate | Binding Sites - genetics | Binding, Competitive - drug effects | Triazoles - pharmacology | Triazoles - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Binding Sites - drug effects | Protein-Serine-Threonine Kinases - metabolism | Staurosporine - pharmacology | Amino Acid Substitution | Jurkat Cells - drug effects | Index Medicus
Journal Article